GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Sale Of Property, Plant, Equipment

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Sale Of Property, Plant, Equipment : ¥241 Mil (TTM As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Sale Of Property, Plant, Equipment?

Shanghai Fosun Pharmaceutical (Group) Co's sale of property, plant, equipment for the three months ended in Sep. 2024 was ¥230 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co gained ¥230 Mil from selling property, plant, and equipment. Shanghai Fosun Pharmaceutical (Group) Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥241 Mil.

Compared with last quarter (¥8 Mil in Jun. 2024 ), Shanghai Fosun Pharmaceutical (Group) Co gained more money from selling property, plant, and equipment in Sep. 2024 (¥230 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Sale Of Property, Plant, Equipment Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.98 8.88 97.10 107.13 9.01

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 1.83 1.17 7.54 230.06

Shanghai Fosun Pharmaceutical (Group) Co Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
SZSE:000963 SZSE:000999 SZSE:002001 SHSE:600085 SHSE:688506 SZSE:000661 SZSE:000423 SHSE:600079 SHSE:600518 SZSE:000513 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
SFOSF:USA 02196:Hong Kong 08HH:Germany 08HH:Germany
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Website
https://www.fosunpharma.com
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Executives
Wu Yi Fang Director
Wen De Yong Directors, senior managers
Guan Xiao Hui Director
Wang Ke Xin Director
Bao Qin Gui senior management
Mei Jing Ping senior management
Li Sheng Li senior management
Feng Rong Li senior management
Wang Dong Hua senior management
Dong Xiao Xian senior management
Su Li senior management
Zhu Yue senior management
Chen Yu Qing senior management
Hu Hang senior management
Liu Yi senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines